%A %T Progress of radiotherapy combined with anti-PD-1/PD-L1 in tumor therapy %0 Journal Article %D 2019 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2019.01.011 %P 49-53 %V 46 %N 1 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10577.shtml} %8 2019-01-08 %X Radiotherapy is widely used in local treatment of tumors. It can not only directly kill tumor cells by damaging DNA, but also have a great impact on the immune system of the body. This effect is not only inhibited, but also more activated. Programmed death1 (PD1) and its ligand 1 (PDL1) antibody, as the most popular immune checkpoint inhibitor, can inhibit tumor growth by restoring and enhancing the immune killing function of T cells. With the deepening of the study, it is found that the combination of the two treatment of tumor, the curative effect is better than the single mode.